Directory
UK-based technology consultancy specialising in programme delivery, systems engineering, and secure digital solutions for government and industry clients, particularly within the defence and security sectors. The company provides expertise across areas including project and programme management, technical consultancy, DevSecOps, cloud-based solutions, and digital transformation. By combining deep sector knowledge with advanced technology capabilities, Apache iX helps organisations navigate complex challenges, deliver critical programmes, and develop secure, resilient systems. The company supports clients across defence and adjacent industries, applying engineering-led approaches to improve capability, efficiency, and operational outcomes.
Advanced materials and acoustics company developing next-generation noise control solutions based on proprietary acoustic metamaterial technology. The company engineers highly structured materials that deliver exceptional sound absorption and noise attenuation while maintaining characteristics such as strength, durability, airflow, and compact form factors. Its technology is used across a range of industries including consumer electronics, automotive, construction, HVAC, industrial systems, and high-fidelity audio. By combining applied physics, computational design, and scalable manufacturing, Metacoust is helping redefine how sound is managed in engineered products and built environments, enabling more efficient, sustainable, and high-performance acoustic solutions.
Global industrial software company that provides engineering, operations, and performance management solutions for some of the world’s most asset-intensive industries. Headquartered in Cambridge, UK, the company develops advanced software that enables organizations to design, operate, and optimize industrial facilities and infrastructure across sectors including energy, manufacturing, chemicals, mining, and utilities. Through its digital twin, industrial intelligence, and cloud-based technologies, AVEVA helps customers improve efficiency, sustainability, collaboration, and operational performance, supporting the digital transformation of industries worldwide.
Cambridge-based biotechnology company pioneering the use of artificial intelligence to transform drug discovery and development. The company has developed a proprietary AI-driven platform that integrates multi-modal biological data to create virtual models of disease at the organ and organism level, enabling researchers to better understand disease mechanisms and identify promising therapeutic interventions. By combining systems biology, machine learning, functional genomics, and computational pharmacology, AI VIVO aims to accelerate the discovery of novel medicines and improve the efficiency of drug development for patients with unmet medical needs.
Cambridge-based biotechnology company specializing in the development, manufacture, and supply of life science research products for academic, pharmaceutical, and biotechnology customers worldwide. The company offers an extensive portfolio of antibodies, proteins, ELISA kits, and other research reagents that support a wide range of applications across immunology, oncology, neuroscience, stem cell research, and molecular biology. With a focus on product quality, scientific expertise, and customer service, Abbexa enables researchers to accelerate discovery and advance innovation in the life sciences sector.
Altium is accelerating the pace of innovation through electronics. Our flagship product, Altium Designer®, is the software tool of choice for designers and engineers who create some of today’s most innovative electronics products. The growing demand for intelligent and connected products is driving advancements in electronics technology. Design trends demonstrate the need to minimize power, reduce package size and energy consumption, and prioritize high-speed design. For over 30 years, Altium has been delivering software that maximizes the productivity of PCB designers and electrical engineers, from concept to finished product.
AMD is the high performance and adaptive computing leader, powering the products and services that help solve the world’s most important challenges. Our technologies advance the future of the data center, embedded, gaming and PC markets. Founded in 1969 as a Silicon Valley start-up, the AMD journey began with dozens of employees who were passionate about creating leading-edge semiconductor products. AMD has grown into a global company setting the standard for modern computing, with many important industry firsts and major technological achievements along the way.
Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing and delivering innovative human therapeutics – focused on areas of high unmet medical need. Leveraging its biologics expertise, Amgen has been a biotechnology pioneer since 1980. Today it is one of the world’s leading independent biotechnology companies, reaching millions of patients globally. Amgen has more than 500 staff in the UK and Ireland, working across Commercial and Research & Development organisations. The UK & Ireland commercial Affiliate operates from offices in Cambridge, Uxbridge and Dublin. In R&D, Cambridge, along with Amgen’s office in Uxbridge, supports clinical development, regulatory affairs and other specialist R&D functions at local, European and global levels – including biostatistical sciences, safety, medical and quality/compliance. Cambridge Science Park was home to Amgen’s first UK office more than 25 years ago and has been at the forefront of Amgen’s European R&D organisation ever since. Today, Amgen’s UK R&D presence is one of the company’s largest hubs outside its global headquarters in Thousand Oaks, California. The UK & Ireland Affiliate is responsible for working with the health services across the UK and in the Republic of Ireland to support the company’s portfolio of medicines and progress its ultimate mission – to serve patients. www.amgen.comwww.amgen.co.uk
Analog Devices, Inc. (NASDAQ: ADI) is a global semiconductor leader that bridges the physical and digital worlds to enable breakthroughs at the Intelligent Edge. ADI combines analog, digital, and software technologies into solutions that help drive advancements in digitized factories, mobility, and digital healthcare, combat climate change, and reliably connect humans and the world. With revenue of more than $12 billion in FY23 and approximately 26,000 people globally working alongside 125,000 global customers, ADI ensures today’s innovators stay Ahead of What’s Possible. The team at Unit 204 is part of the Digital Healthcare Group focusing on Biomedical Development of new technologies.
Astex Pharmaceuticals is a leader in innovative drug discovery and development, committed to the fight against cancer and diseases of the central nervous system. Robust proprietary oncology portfolio with multiple drugs in mid-late stage clinical development Developing CNS portfolio of novel targeted therapeutics for defined neurodegenerative disease populations Productive partnerships with top-tier pharmaceutical companies Visionary leadership backed by a world-class management team Oncology and CNS Focused We are a leader in innovative small-molecule therapeutics with particular expertise in fragment-based drug discovery, the most important advance in discovery chemistry in the last 20 years. Our primary areas of focus are oncology and diseases of the CNS. Astex is developing a proprietary pipeline of novel targeted therapies and has a number of partnered products being developed under collaborations with leading pharmaceutical companies. In October 2013 Astex became a wholly owned subsidiary of Otsuka Pharmaceutical Co. Ltd., Tokyo, Japan. The Otsuka Group employs approximately 43,000 people globally, and its products are available in more than 80 countries worldwide. For more information about Otsuka Pharmaceutical please visit our website.
Established in 1982, Alan Boswell Group is a top 15 independent insurance broker and one of the largest regional independent financial planners. We employ nearly 400 people from our eight offices across Norfolk, Suffolk, Cambridgeshire, and Lincolnshire. Our Cambridge team of more than seventy industry professionals all work together to provide a full range of commercial insurance, credit insurance, personal insurance, and financial services solutions to a wide customer base across the UK – many of them with worldwide operations.
As one of the industry’s leading cloud communications platforms for service providers, Alianza helps our customers supercharge growth and reduce costs while modernizing and transforming core communications networks. Our team of experts is passionate about simplifying service delivery and ensuring first-rate customer experiences. www.alianza.com
Brazilian Jiu-Jitsu and martial arts academy located on the park, providing occupiers with access to high-quality fitness, self-defence, and wellbeing activities. The academy offers expert-led training in Brazilian Jiu-Jitsu for all experience levels, from complete beginners to advanced practitioners, within a welcoming and inclusive environment. As part of the park’s amenity offering, BTT Cambridge promotes physical fitness, mental resilience, and community engagement, giving occupiers a convenient opportunity to stay active, develop new skills, and enhance their overall wellbeing.
Bulgin, a Global Connectivity Consultancy that is widely recognised as a leading manufacturer of environmentally sealed connectors and components. With over 95 years of experience in the industry, our vision is to continue to innovate and develop products and services to cater for our global customer base across a variety of markets.
Biofidelity, a private company founded in 2019 in Cambridge, UK, is revolutionising access to best-in-class cancer diagnostics, breaking down the barriers to better screening, monitoring and treatment for all cancer patients. Our disruptive diagnostic technology platform provides comprehensive panels of clinically actionable data based on ultra-sensitive detection of the markers recommended in cancer treatment guidelines, enabling all patients to be prescribed the right drug at the right time. Biofidelity is developing panels for non-small cell lung and colorectal cancer, with potential in a broad range of cancers as well as in the detection of resistance to therapy and disease recurrence.
BRDG (Bridge) is a next generation WorkTech social platform transforming how talent connects to opportunity by making trust, skill, and visibility the foundation of modern work. We support freelancers, students & creators (especially those from overlooked or underrepresented backgrounds) to get seen, get trusted, get hired and Connect. We solve three key problems and here’s how: Invisible talent – We replace static CVs with live visual profiles and proof-based productivity logs that show what you’re working on, not just what you’ve done. Fragmented trust – We eliminate fake reviews with biometric ID verification, smart contracts, and on-chain reputation tracking. Disconnected ecosystems – We unify hiring, learning, networking,and collaboration into one social, intelligent platform built for real world growth. BRDG is building the trust layer for the future of work, ensuring the opportunities of the future are accessible to everyone, no matter their circumstance. More information here: BRDG
Bright Horizons Cambridge Science Park cares for children from 3 months to 5 years of age, on a full time or part time basis. Open from 7.30am-6.00pm the nursery is fully inclusive providing hot healthy meals cooked on site, nappies, wipes, formula for babies and creams such as sun and nappy cream. Every age group has access to their own outdoor garden space and a large communal courtyard for all of the children to enjoy. Bright Horizons Cambridge Science Park is the chosen dedicated on-site nursery for Cambridge Science Park and we offer a perfect child care solution for all parents and employees located on the Science Park.Being located within a science park enables the nursery to suit the needs of working parents, offering a secure and versatile environment and simplifying drop-offs and pick-ups before and after work hours. With over 17 years total management experience, our nursery Manager Natasha May & Deputy Manager Rebecca Brown look forward to helping you choose your child care setting & showcasing our nursery to you. It is our mission to continue to make a difference to children, families and employers, and to provide the highest quality early care and education for each child in our nursery, every day. Bright Horizons Family Solutions is the UK’s leading childcare provider. With a portfolio of over 300 nurseries and a 30 year history, it has been trusted by many families to provide children with naturally inspiring, exceptional care and education for the early years.
Broadcom is a global leader in wired and wireless broadband communications semiconductors. Products enable the convergence of high-speed data, high-definition video, voice and audio at home, in the office and on the go. Broadcom provides manufacturers of computing and networking equipment, digital entertainment and broadband access products, and mobile devices with the industry’s broadest portfolio of state-of-the-art system-on-a-chip and software solutions.
Bard Pharmaceuticals Ltd is the Production & Supply Chain business of the Napp Pharmaceutical Group. Bard is part of a broader network of independently associated companies that are present in 33 countries across Europe, and others throughout the rest of the world. At the forefront of controlled release technology, we manufacture, pack and supply products to over 40 countries, helping to bring benefits to many patients’ lives.
Science for a Better Life. As an innovative and research-based company, Bayer CropScience is committed to providing efficient and tailor-made solutions for its customers in the UK agricultural, garden and amenity markets. Committed to open communication, Bayer CropScience is setting the standard in areas of product and environmental stewardship.
World-leading educational assessment organisation and a department of the University of Cambridge. The organisation develops and delivers qualifications, examinations, assessments, and educational services that support millions of learners, teachers, schools, and institutions worldwide. Through its international education, English language assessment, and UK qualifications businesses, Cambridge helps learners demonstrate their knowledge and skills while advancing educational standards globally. Drawing on more than 160 years of expertise in assessment, research, and education, the organisation combines academic rigour with innovation to create trusted qualifications and learning solutions used in over 160 countries.
UK-based medical technology company focused on developing innovative devices and solutions that improve patient care and clinical outcomes. The company specialises in the design and commercialisation of minimally invasive medical technologies and healthcare products that support hospitals and clinicians in delivering safer, more efficient treatments. By combining engineering expertise with clinical insight, CHI aims to address unmet needs in healthcare through practical, scalable innovations that enhance procedural performance, reduce risk, and improve patient recovery. The company operates within the broader medical technology and life sciences sector, contributing to advancements in modern healthcare delivery.
UK-based technology company specialising in smart infrastructure and Internet of Things (IoT) solutions for built environments and industrial applications. The company develops connected sensing and data platforms that enable real-time monitoring, control, and optimisation of physical assets across sectors such as real estate, facilities management, energy, and smart cities. By integrating edge devices, cloud software, and data analytics, cThings helps organisations improve operational efficiency, reduce energy consumption, and enhance sustainability performance. Its solutions are designed to support scalable deployment of IoT systems, enabling customers to gain actionable insights from buildings and infrastructure networks.
Cambridge-based healthcare technology company specializing in the research, development, manufacturing, and commercialization of innovative diagnostic solutions, life science tools, and digital health technologies. Founded in 2009, the company works at the intersection of science, engineering, and healthcare, partnering with academic institutions, healthcare providers, and industry leaders to bring novel technologies from concept to market. Camtech’s expertise spans point-of-care diagnostics, microfluidics, lateral flow assays, laboratory validation, regulatory support, and artificial intelligence–enabled healthcare solutions. Through its integrated approach to innovation and commercialization, the company aims to improve access to accurate, rapid, and patient-centered healthcare technologies worldwide.
Data-driven biopharmaceutical company focused on identifying, enhancing, and commercializing high-potential therapeutic assets through a combination of artificial intelligence, scientific innovation, and strategic partnerships. Originally established as Conduit Pharmaceuticals, the company leverages AI-driven analysis, solid-form chemistry, and asset repositioning strategies to unlock additional value from clinically validated drug candidates. Rather than pursuing traditional, capital-intensive drug development, CDT Equity focuses on generating intellectual property, expanding therapeutic applications, and out-licensing assets to pharmaceutical partners for later-stage development and commercialization. Headquartered in Naples, Florida and listed on the NASDAQ, CDT Equity is building a diversified portfolio across autoimmune diseases, oncology, dermatology, infertility, and animal health while maintaining a capital-efficient business model designed to accelerate innovation and create long-term shareholder value.
The Next Wave Of Deep Tech Innovation Will Fundamentally Change The Way The World Works. Cambridge Future Tech Works To Make This Happen. The Cambridge Future Tech (CFT) Venture Builder is our vehicle for developing high potential businesses utilising innovative technologies in collaboration with innovators. The CFT team partner with founders from ‘Day-Zero’ working to turn nascent deep technology innovations into viable businesses with the resources and structure required for success. We drive the commercialisation of bleeding edge innovation. We work directly with researchers and inventors to commercialise their technologies. Our in-house team utilises expertise, contacts and resources to turn innovation into product and establish an effective route-to-market. We take on both fundraising and the building of a first class team. We start building customer relations early in the development process to ensure commercialisation is efficient and meets market needs. Cambridge Future Tech turns early technology and research projects into commercially viable ventures.
We are a medical device and algorithm company using artificial intelligence and computer science for the prevention of heart disease and stroke. We are also interested in the effect of inherited cardiac disorders as a common cause for electrical disturbances in the heart.
Cambridge Mechatronics Limited (CML) is a multidisciplinary engineering company developing industry-leading precision motion solutions for use across a variety of markets, including smartphones, AR/VR, wearables and many more.
Cambridge Science Centre makes science fun and friendly for all the family through our hands-on and interactive activities and exhibits. Open at weekends and during school holidays for family visits, you can buy your membership and enjoy a whole year of STEM-based exploration and discovery.
Employing the latest piezoelectric sensor design, 3D Multi-Touch provides an elegant solution to position and force sensing. The low cost force sensor needs no external power, adds no additional thickness or weight, and detects both location and force at the same time. 3D Multi-Touch allows one, two or more touches simultaneously, each with separate force detection, providing app developers with a whole new dimension to indulge their imagination. 3D Multi-Touch is next-generation technology that’s compatible with LCD and OLED displays, and unlike first-generation systems, fits above the display panel, significantly reducing manufacturing complexity and cost.
Cerevance is a new pharmaceutical company focused on central nervous system diseases. Our strengths include a powerful technology platform, a pipeline of novel discovery-stage and clinical-stage compounds and a proven team. We believe that we are well positioned to deliver life-changing therapeutics for patients who have brain-related disorders while creating value for our employees and shareholders.
CN Bio is a leading bioengineering company specialising in single and multi-organ microphysiological systems and innovative lab technologies. We aim to provide systems that generate clinically translatable data that can enhance the development of tomorrow’s medicines. Consumer goods, chemical companies and regulators use our microphysiological (MPS) systems and consumables to analyze novel compounds, assessing toxicity and safety in cells and organ models. We also support research scientists who need data-rich in vitro studies to investigate a wide range of biological processes in fields including oncology, infectious diseases, metabolism and inflammation. Our technologies enable researchers to work on innovative modalities including gene editing, therapeutic antibodies/proteins and cellular therapies.
Creasallis is a Cambridge based startup looking at re-engineering antibodies to improve their penetration into solid tumours. It has its own portfolio of solid tumour antibody-based drugs, as well as collaborates with antibody drug developers to improve their existing portfolio. www.creasallis.com
‘We are building a new method for instrument free single cell analysis’ Our transformative new technology for single cell genomics replaces complex hardware and manual time-consuming workflows with a simple, instrument-free, solution-based, kinetic confinement assay that plugs seamlessly into any molecular biology laboratory.
CW is the leading international community for companies involved in the research, development and application of wireless and mobile, internet, semiconductor and software technologies. With over 400 members from major network operators and device manufacturers to innovative start-ups and universities, CW stimulates debate and collaboration, harnesses and shares knowledge, and helps to build connections between academia and industry. CW’s 19 Special Interest Groups (SIGs) provide its members with a dynamic forum where they can network with their peers, track the latest technology trends and business developments and position their organisations in key market sectors. CW also organises major conferences and start-up competitions along with other high-quality industry networking events and dinners. With headquarters at the heart of Cambridge, UK, CW partners with other international industry clusters and organisations to extend its reach and remain at the forefront of global developments and business opportunities.
Cambridge Consultants is a world-class supplier of innovative product development and technology consulting. Working from our laboratories in Cambridge, UK, Boston and Seattle, USA, we have all the in-house skills needed to help you to create an innovative concept right the way through to taking your product into manufacturing. Most of our projects deliver prototype hardware or software and trials production batches. Equally, our technology consultants can help you to maximise your product portfolio and technology roadmap. We’re not content just to create me-too products that make incremental change; we specialise in helping companies achieve the seemingly impossible. We work with some of the world’s largest blue-chip companies as well as with some of the smallest, innovative start-ups who want to change the status quo fast. Founded over 50 years ago, the company combines exceptional people, proven processes and excellent facilities, backed by an enviable track record of creating world-firsts, to deliver real value to our clients. To find out more about our work please visit www.cambridgeconsultants.com We are one of the region’s leading employers and have been listed in ‘The Sunday Times Top 100 companies to work for’ list for the past three years.
Mobile and web app developers specialising in apps for the health sector. Our team can help with app design, development, hosting and navigating the regulatory approval process, working with you to deliver tailored and innovative solutions.
Organisation focused on supporting the growth of Africa’s digital and innovation ecosystems by investing in and enabling technology-driven entrepreneurship across the continent. It works to strengthen early-stage startups and scale-ups by providing funding, technical assistance, and access to networks of investors, corporates, and development partners. The agency places particular emphasis on digital inclusion, supporting founders building solutions in areas such as fintech, agritech, healthtech, and e-commerce. Through its programs and partnerships, Digital Africa aims to accelerate the development of sustainable digital economies and foster innovation-led economic growth across African markets.
Dr. Reddy’s Laboratories Ltd. is an integrated global pharmaceutical company with a commercial presence in more than 20 countries, and wholly-owned subsidiaries in US, UK, Russia, Germany and Brazil and joint ventures in China, South Africa and Australia. Dr. Reddy’s has over 20,000 employees working across the globe and a network of 25 manufacturing facilities and seven R&D centres, including Cambridge. In our Cambridge laboratories, Dr Reddy’s develops and uses advanced chemistry skills, including world-leading bio- and chemocatalysis technology, to develop routes to APIs. Projects are performed for both internal customers and, via our Custom Pharma Services division, for external customers. Our main focus is developing technical solutions for the production of complex single enantiomer intermediates and APIs. Our technologies enable cleaner, quicker, and more efficient routes to these target molecules. The site was founded more than 25 years ago and has been part of Dr Reddy’s since 2008.
Dassault Systèmes, the 3DEXPERIENCE Company, world leader in 3D design software, 3D Digital Mock Up and Product Lifecycle Management (PLM) solutions, provides businesses and people with virtual universes to imagine sustainable innovations. Its 3DEXPERIENCE Platform leverages the Company’s world-leading 3D software applications to transform the way products are designed, produced, and supported, enabling businesses to craft delightful customer experiences.
With DisplayLink, expanding your visual workspace has never been easier or more affordable. Our technology makes it really easy to connect any display to any computer that supports USB or WiFi (which means any computer). We call this Plug and Display. DisplayLink is supported by the major PC computer and accessories companies and is designed into docking stations, graphics adapters, and monitors. We are constantly creating new ways to support other platforms and devices, including Ultra HD 4K displays, tablets, and wireless devices. We are a privately held company with offices in the USA, Asia and Europe.
UK-based technology company developing digital platforms and software solutions designed to improve access to information, services, and computing in both consumer and enterprise contexts. The company focuses on building scalable, user-centric technology products that combine software engineering, cloud infrastructure, and data-driven design to deliver accessible and efficient digital experiences. Its work spans areas such as operating systems, digital services, and platform technologies aimed at supporting connectivity and usability across a range of environments and user needs.
Biotechnology company developing next-generation, off-the-shelf cell therapies aimed at delivering affordable and scalable treatments for cancer and rare diseases. Based at the Babraham Research Campus near Cambridge, UK, the company combines expertise in gene editing, stem cell programming, and cellular engineering to create advanced cellular medicines with enhanced disease-fighting capabilities. Empyrean is building a proprietary platform of technologies, cellular assets, and manufacturing processes designed to rapidly produce novel therapeutic cell products, with the goal of expanding access to transformative treatments worldwide
Everyone at Embrace has a shared ambition to do great work, to challenge thinking, create solutions and bold strategies that deliver beyond expectations. Our diverse experience and expertise allows us to implement global and local strategies across a broad range of contexts and geographies. We work with a strong group of partner suppliers who share the same ethos for producing excellence in communications and the event space.
Endomag is a global company headquartered in Cambridge’s Science Park, with an additional office in Austin, Texas. Originally founded in 2007 by professors at University College London (UCL) and the University of Houston, Endomag harnesses the power of magnetics to enable a better standard of cancer care. Many of the world’s leading physicians and hospitals use our technologies to help women with breast cancer avoid surgery when it isn’t needed, and experience better outcomes when it is. At the heart of the company’s product platform is the Sentimag® localisation system. The Sentimag® system features a probe that works like a metal detector, which when placed near the skin’s surface is used to detect Endomag’s magnetic seed (Magseed®) or liquid tracer (Magtrace®), for tissue localisation and sentinel node biopsy procedures. To date, the company has helped over 130,000 women around the world access more precise and less invasive breast cancer care.
EnSilica is a leading fabless supplier of complex mixed signal ASIC to OEMs and system houses. The company has world-class expertise in designing and supplying custom RF, mmWave, mixed signal and digital ICs to its international customers in the automotive, industrial, healthcare and communications markets. The company also offers a broad portfolio of core IP covering cryptography, Radar and communications systems. EnSilica has a track record in delivering high quality solutions to demanding industry standards. www.ensilica.com
Excelitas Noblelight Ltd is the market leader in the design and manufacture of high performance flash and arc lamps, utilised in several market areas including Laser (Industrial and Medical), IPL and Solar Simulation.
Emberion develops and produces graphene photonics and electronics that will revolutionise infrared photodetectors and thermal sensors in applications ranging from hyperspectral and thermal imaging to night vision and X-ray detection. We deliver tailored, high-quality solutions for those in need of superior technical performance and improved return-on-investment in R&D. Our passion is to take imaging and sensing quality to a new level.
EDX Medical Group Plc. is a global specialist in digital clinical diagnostics; developing and supporting high-performance products and services to provide cost-effective prediction of disease risk, inform clinical decision-making, enable personalised healthcare and accelerate the development of new medicines for cancer, neurology, heart disease and infectious diseases.
Cambridge-based financial technology company that helps banks, fintechs, and payment providers combat fraud, anti-money laundering (AML), and financial crime through a combination of AI-powered software and specialist industry expertise. Founded by leaders with extensive experience in fraud prevention and payments, the company develops intelligent platforms that enable organisations to detect emerging threats, automate compliance processes, improve operational efficiency, and reduce financial risk. By combining advanced analytics, machine learning, workflow automation, and embedded advisory services, Fortify helps customers strengthen their financial crime controls while adapting to an increasingly complex regulatory and threat landscape.
Vibrant food and social amenity on the park, bringing together a rotating selection of high-quality street food vendors that offer a diverse range of freshly prepared cuisines. Providing occupiers and visitors with convenient access to varied lunch and refreshment option.
Filtronic is a leading designer and manufacturer of high-performance RF and mmWave components and subsystems for mission-critical communication networks. Established in 1977, the company partners with global technology leaders across Space, Defence, Telecommunications, and Critical Communications sectors.
Its portfolio includes advanced transceivers, power amplifiers, filters, and custom solutions operating within K-band to W-band, up to 175 GHz. These technologies support applications such as 5G backhaul, satellite communications, and secure defence systems. A recent collaboration with SpaceX highlights Filtronic’s expertise in delivering advanced satellite connectivity solutions.
Filtronic provides end-to-end services, including design, manufacturing, and testing, ensuring high quality and reliability through vertical integration. Its hybrid manufacturing capabilities, including microelectronic assembly, allow tailored solutions to meet specific client needs.
With decades of innovation and a collaborative approach, Filtronic is committed to advancing faster, more reliable communication networks for the future.
Frontier has built a uniquely diverse track record comprising games that have defined genres, been critically acclaimed and sold many millions of copies. Frontier is currently 250 strong and growing, as it recruits for its exciting next-generation games console projects.
World’s leading provider of Adaptive Behavioural Analytics technology. Featurespace is dedicated to making the world a safer place for our clients and their customers. Financial crime is an enormous issue for society – technology can combat it. With the support of our customers, we have developed market-leading solutions to fight financial crime – using real-time machine learning software powered by our invention – Adaptive Behavioral Analytics. Our technology and results are recognized as the best worldwide for fighting financial crime. With our scientific roots, we couldn’t make that claim if it had not been statistically verified – over and over again. Our achievements are due to our collaborative approach and ability to attract and retain the best customers, talent and investors. It’s a rare achievement to bring a new technology to market, to achieve financial success and – most importantly of all – to make customers proud to be using technology developed to outsmart the perpetrators of real-time financial crime.
FlexEnable’s award-winning flexible technology platform and unique FlexiOM™ materials bring the highest optical performance and lowest cost approach to flexible, ultra-thin and lightweight active optics and displays. The organic thin-film transistor (OTFT) backplane process developed by FlexEnable, allows transistors to be manufactured at less than 100°C – by far the lowest temperature process for transistor manufacturing in the world. This allows, for the first time, commonly available and optically ideal flexible bio-degradable substrates such as TAC film to be used instead of glass. FlexEnable’s game-changing technology is used to make active-matrix flexible displays and flexible active liquid crystal (LC) optical films which are thin, light and conformable to almost any surface. OTFT display technology is already on the market today incorporated into a consumer product – a crypto wallet device with an E Ink display uniquely wrapped around a 180-degree bend. Today, FlexEnable has around 450 patents and patent applications globally for OTFT and LC cell materials, processes and device architectures. With an established supply chain for OTFT production, FlexEnable has technology transfer programmes and mass production underway with several leading display manufacturers in Asia as well as commercial programmes with some of the world’s biggest brands in consumer electronics.
Applied artificial intelligence company that designs and deploys specialised AI systems for enterprise organisations. Rather than focusing on generic AI tools, the company builds domain-specific solutions that are embedded directly into customer workflows to solve operational challenges and deliver measurable business impact. GoodFolio combines proprietary models, industry expertise, and forward-deployed engineering teams to develop AI systems across areas such as financial compliance, strategic intelligence, healthcare innovation, and consumer protection. Headquartered in London with additional international locations, the company operates as a venture studio and AI systems builder, working with enterprise clients to translate AI capabilities into practical, scalable applications that improve performance and decision-making.
Gearset is the complete, enterprise-ready Salesforce DevOps platform that empowers teams to deliver faster, safer, and more efficiently across the entire DevOps lifecycle. From metadata and CPQ deployments to CI/CD, testing, code scanning, sandbox seeding, backups, archiving, and observability, Gearset gives full visibility and control over your Salesforce environments. Trusted by over 3,000 organizations — including McKesson, IBM, and Zurich — Gearset combines advanced governance, built-in audit trails, and robust compliance with ISO 27001, SOC 2, GDPR, CCPA/CPRA, and HIPAA. Gearset enables teams to meet the highest standards of security and reliability. Designed for rapid onboarding and ease of use, Gearset delivers enterprise-grade power through an intuitive interface — uniting security, scalability, and simplicity in a single platform.
Cambridge-based synthetic biology company developing advanced microbial expression platforms for the production of complex proteins and other high-value biological molecules. The company combines a proprietary library of diverse, unconventional microorganisms with artificial intelligence and machine learning to identify the optimal host system for manufacturing proteins that are difficult or impossible to produce using conventional expression technologies. By enabling improved protein folding, post-translational modifications, stability, and yield, HERlab aims to accelerate innovation across biopharmaceuticals, cellular agriculture, biomaterials, and industrial biotechnology. Through its novel bioproduction platform, the company is helping unlock new possibilities for the scalable and sustainable manufacture of next-generation biological products.
UK-based independent video game development studio best known for creating innovative, procedurally generated gaming experiences. Founded in 2008 by a group of former Electronic Arts developers, the company gained international recognition for titles such as Joe Danger and No Man’s Sky. Hello Games focuses on building ambitious, technology-driven games that emphasise exploration, creativity, and large-scale procedural worlds. The studio is widely recognised for its ongoing development and expansion of No Man’s Sky, continuously delivering new content and technical improvements years after launch.
We are a HR, Recruitment and Training Consultancy for SME businesses to the Technology, Insurance and Professional Services sectors. Providing personalised, professional people solutions that are based around the outcomes you’re hoping to achieve, rather than the challenges you’re faced with.
Huawei is a major investor in the UK, dedicated to help the UK to remain a leader in the global ICT sector. Huawei’s strategy is to build a better connected UK. Its technology and employees in the UK help to connect communities every day. Since it opened its first office in the UK in 2001, Huawei has grown from being a telecoms provider to a fully integrated ICT supplier. It is now a central player in the deployment of the UK’s broadband and telecoms networks and is partnering with all the major UK operators to deliver the fastest speeds and most comprehensive connectivity.
HUBER+SUHNER Polatis continues research into optical switching technologies. It has established a new performance benchmark for optical switches, based on patented DirectLight technology. This is being applied to create a non-blocking Direct Beam Steering (DBS) architecture, which points input and output fibres at each other, providing ultra low loss connections.
Hedera Innovations is a software development consultancy that enables organisations to bring complex embedded products to market quickly using Open Source Software. With over 15 years of expertise in the field we will guide you through the maze of design, component selection, tool chains, and licensing issues to enable you to maximise the benefits of using Open Source Software. We work closely with our clients to deliver technology components, customised development services and training and consultancy to meet your needs as and when required. Our approach emphasises working closely with the client throughout the entire lifecycle – from requirements capture to development, delivery and on-going maintenance. Our flexibility enables us to support both highly focused tasks and a complete turnkey solution.
Hereworks is an award-winning company that provides Smart Building solutions, including Master Systems Integration, along with our own patented software, Hereworks Happy™, a dashboard to provide insight into the information gathered from a Smart Building. Whether a complete digital transformation or an update to existing systems, Hereworks designs, installs, and implements digital infrastructures to meet their client’s unique requirements to connect and inspire their people. Hereworks draws on the experience of their people, as well as over 70 years of project management experience, to provide the best solutions.
UK-based deep-tech semiconductor company developing next-generation non-volatile memory solutions for edge computing and artificial intelligence applications. Founded in 2017 as a spinout from University College London, the company has pioneered a silicon oxide–based resistive random-access memory (RRAM) technology that delivers significantly faster read and write speeds, lower power consumption, and seamless compatibility with existing CMOS semiconductor manufacturing processes. By enabling high-performance memory to be integrated directly onto processor chips, Intrinsic aims to overcome the limitations of conventional flash memory and accelerate the development of smarter, more energy-efficient devices across edge AI, IoT, and microcontroller markets.
The UK’s Internet Watch Foundation (IWF) is a not-for-profit charity working globally to find and remove child sexual abuse imagery from the internet.
Established in 1996, the organisation’s dedicated analysts scour the internet to identify child sexual abuse material and then work internationally with technology companies and law enforcement to ensure those images and videos are removed.
The IWF also provides services and datasets for tech companies to help prevent the distribution of this criminal material.
IQVIA is a leading global provider of advanced analytics, technology solutions, and clinical research services to the life sciences industry. IQVIA creates intelligent connections across all aspects of healthcare through its analytics, transformative technology, big data resources and extensive domain expertise. IQVIA Connected Intelligence™ delivers powerful insights with speed and agility — enabling customers to accelerate the clinical development and commercialization of innovative medical treatments that improve healthcare outcomes for patients. With approximately 87,000 employees, IQVIA conducts operations in more than 100 countries.
We manufacture super-adsorbent nanomaterials which can dramatically reduce the cost of separating, storing, and transporting gas. Separating, storing, and transporting gas using traditional technologies is costly and uses a great deal of energy. At Immaterial we work on an alternative technique that offers huge cost savings to industry through the use of metal-organic framework (MOF) materials that adsorb and separate gases at the molecular level.
We are the world’s first data-driven invention company. Our cutting-edge technology has powered the creation of over 1,500 patented inventions, showcasing the exceptional capabilities of our software and invention services. Iprova’s team of professional inventors create and deliver a stream of ready-to-use, and patent inventions within an agreed target area. Our partly contingent business model means we are strongly incentivised to create inventions that our clients – at their discretion – choose to accept. By exploring many millions of global changes in real-time, our software identifies and connects inventive signals, enabling the creation of new patentable inventions with unparalleled speed and efficiency. Find out more here
UK-based digital product and experience design studio specialising in the creation of user-centred software, websites, and digital platforms. The company works with startups and established organisations to design and build intuitive digital products, combining expertise in UX/UI design, software development, and product strategy. By focusing on usability, accessibility, and modern design principles, Jaunty Bear helps clients transform ideas into engaging digital experiences that support business growth and improve customer interaction.
UK-based energy and mobility technology company that develops digital platforms to support the delivery, installation, and management of low-carbon technologies. The company’s software solutions are designed to streamline complex operational workflows for organisations involved in electric vehicle charging, heat pump installation, and wider energy transition services. By connecting customers, field engineers, installers, and service providers through a single digital ecosystem, Jumptech helps improve coordination, reduce administrative burden, and accelerate the rollout of sustainable energy infrastructure. With a focus on decarbonisation and operational efficiency, the company supports utilities, energy providers, and net-zero service companies in scaling clean technology adoption.
A leader in creating deep and engaging experiences on PC and mobile, Jagex was founded in 2001 and is today one of the UK’s biggest and most respected video game developers and publishers Famed for its flagship MMOs RuneScape and Old School RuneScape, Jagex has welcomed more than 260million player accounts to its world and created a $1bn lifetime franchise revenue. Today the RuneScape franchise exists beyond running games in live operations; our titles are living games that connect and inspire millions of players, with content and experiences both inside and outside of inexhaustible game worlds. Both RuneScape and Old School RuneScape, on PC and mobile, offer ever-evolving, highly-active worlds and our community-focussed development ethos empowers players to have a real say in how each game is shaped. Jagex is expanding and extending its portfolio with fresh franchise titles, new IP and, in 2018 launched Jagex Partners, delivering third-party publishing and operational services exclusively for the living games of the future. Jagex employs more than 360 people at its Cambridge headquarters and is on the hunt for talented people to work across the business to help the company to achieve yet another year of record growth and player satisfaction.
Johnson Matthey’s vision is for a world that’s cleaner and healthier, today and future generations. We are leaders in sustainable technologies and we apply our science to solve our customer’s most complex problems. We work with customers and partners across markets from pharmaceutical and medical to automotive, industrial and chemical production.
We supply and install laboratory fume cupboards and furniture; our range is particularly designed for th laboratory and clean room markets as its manufactured from steel.
Cambridge-based legal and technology company that provides AI-powered patent management services for startups and scaling technology businesses. The company combines proprietary artificial intelligence tools with experienced patent attorneys to streamline the full intellectual property lifecycle, including invention capture, drafting, filing, prosecution, and portfolio management. Its platform is designed to make patent protection faster, more transparent, and more cost-effective compared to traditional legal firms, while maintaining attorney-led quality and compliance. By integrating workflow automation, strategic IP insights, and expert legal review, Lightbringer helps deep-tech companies protect innovation and build scalable patent portfolios more efficiently.
Semiconductor and life sciences technology company developing next-generation biochip platforms based on thin-film transistor (TFT) semiconductor technology. With its UK research and business development centre located in Cambridge, the company combines expertise in semiconductor engineering, synthetic biology, and biotechnology to create high-throughput tools for DNA synthesis, microarray applications, molecular diagnostics, and biological sensing. LinkZill’s proprietary TFT biochip platform enables precise control of biological reactions at scale, helping researchers and industry partners accelerate innovation in genomics, synthetic biology, and life science research. Serving customers across academia and industry worldwide, the company is advancing the convergence of semiconductor technology and biotechnology to support the next generation of scientific discovery and healthcare innovation.
Lucideon’s Healthcare Materials Technologies office is based on the Science Park.
Sustainability-focused organisation supporting businesses and communities in accelerating the transition to a low-carbon future. The company provides expertise, guidance, and solutions to help organisations measure, reduce, and manage their environmental impact, with a focus on achieving net zero goals. Through sustainability strategy, carbon reduction initiatives, and practical implementation support, Mission Net Zero helps organisations navigate the challenges of decarbonisation and embed more sustainable practices into their operations. By combining environmental expertise with actionable solutions, the organisation supports the development of a more resilient and sustainable economy.
UK-based robotics and autonomous systems company developing advanced unmanned aerial and ground vehicle technologies for industrial, defence, and infrastructure applications. The company focuses on integrating robotics, artificial intelligence, and sensor fusion to create autonomous platforms capable of operating in complex and dynamic environments. Its solutions are designed to support use cases such as surveying, inspection, mapping, and data collection across sectors including energy, construction, and critical infrastructure. By combining hardware engineering with intelligent software systems, Mavinci Dynamics aims to improve operational efficiency, safety, and data accuracy in environments that are difficult, hazardous, or costly for human operators to access.
semiconductor company developing next-generation wireless connectivity solutions based on the Wi-Fi HaLow (IEEE 802.11ah) standard. Founded by a team of experienced wireless engineers, the company designs ultra-low-power, long-range Wi-Fi chips and modules that enable reliable connectivity for Internet of Things (IoT), industrial, smart city, agricultural, and consumer applications. Morse Micro’s technology delivers significantly greater range, lower power consumption, and improved penetration through walls and obstacles compared with conventional Wi-Fi, helping to connect devices in environments where traditional wireless networks are limited. With a growing global presence, the company is driving the adoption of Wi-Fi HaLow as a key enabler of the next generation of connected devices and infrastructure.
MicrosensDx is a dynamic and ambitious innovator at the leading edge of the diagnostics sector for more than 20 years. MicrosensDX is building a global brand, delivering sample to result molecular solutions, transforming patient outcomes with fast accurate diagnosis. Our vision is to build a global brand delivering innovative diagnostic solutions which transform patient outcomes. Our dedicated team is aligned to our mission of building a global brand, delivering sample to result molecular solutions, transforming patient outcomes with fast accurate diagnosis.
At Microsoft in Cambridge, our mission is to transform the world through deep research. We do this by working together in an interdisciplinary way, in close collaboration with the broader Microsoft business, to ensure that we are designing robust and trusted technologies to empower millions of people worldwide. To truly understand how we can empower others, we need to put the people at the centre of what we do. In a hybrid world the dynamics of how we work, communicate and feel a sense of connection with others is evolving, which is a significant opportunity for our research. The site incorporates custom-made, state-of-the-art, optical labs and office space, for the Cloud Systems Futures team and Azure for Operators team.
Milltons brings together patients and researchers in order to find new therapeutic approaches to painful yet neglected chronic illnesses. We are building an ever-growing community of patients, researchers, medical associations and universities actively involved in large-scale Pan-European studies. Together, we are devising new therapeutic mechanisms to ease the pain and stop deterioration of the illnesses. During the current COVID 19 situation, we have built a charitable program designed to reduce stress, inflammation and degeneration for chronic patients; conditions which are all accelerated by quarantine. Our members will be able to learn, implement and, most importantly, measure their progress in all 3 stages- reducing stress, reducing inflammation and slowing down cellular degeneration.
Mogrify® has developed a proprietary suite of platform technologies that utilize a systematic big-data approach to direct cellular reprogramming (Rackham et al., Nature Genetics, 2016) and the maintenance of cell identity (Kamaraj et al., Cell Systems, 2020). The platforms, MOGRIFY® and epiMOGRIFY®, developed over a 12-year period via a multi-national research collaboration, deploy next-generation sequencing, gene regulatory and epigenetic network data to enable the prediction of the transcription factors and growth factors required to produce any target human cell type from any source human cell type. The platforms can be used to enhance existing stem-cell forward programming methods, or can bypass development pathways altogether, affecting a direct transdifferentiation between a mature cell type to another mature cell type. Mogrify is applying its proprietary and award-winning platforms to generate the functional cell types required to transform the lives of patients, by delivering a novel class of in vivo reprogramming therapies across ophthalmology, otology, metabolic and other areas of degenerative disease. Uniquely positioned to address a regenerative medicine market estimated to be worth $150 billion USD by 2028, Mogrify is commercializing its technology via a combination of in vivo reprogramming therapy development, co-development partnerships, as well as the exploitation of the platform in other therapeutic and non-therapeutic applications. Based in Cambridge, UK, the Company has raised over $40 million USD funding from Parkwalk, Ahren Innovation Capital, 24Haymarket, Trend Investment Group, Dr. Darrin M. Disley, OBE, Dr. Jonathan Milner and the University of Bristol Enterprise Fund III, as well as strategic investors; Astellas Venture Management.
Mundipharma International Limited is part of a global network of independent associated privately owned pharmaceutical companies which was founded by physicians more than 60 years ago to help improve the health and quality of life of people everywhere. Working across 23 countries in Europe, we partner with organisations to accelerate the development of medicines and have a proven track record in building brands that maintain leading positions. We look at things from a different perspective and are expert at identifying and developing the potential of medical innovations to help improve patients’ lives in meaningful ways. We develop medical innovations by collaborating with research institutions and partner companies that can, with our expertise and support, achieve their full potential and create shared value for stakeholders. We are successfully developing an increasingly diversified portfolio of medicines built on our proud heritage of over 60 years in pain management We recognise the pressures on healthcare systems and believe that the only innovations that matter are the medicines that are successfully launched and made available for the benefit of patients. We therefore take a pragmatic approach to assessing pharmaceutical innovation in order to develop responsible and sustainable medicines that create shared value.
Mundipharma IT Services helps its clients to improve patients’ lives. The company understands how to use IT to transform businesses and creates value by building and operating cost effective solutions all around the globe.
The 21st century will be marked by the convergence of artificial intelligence, fuelled by Moore’s Law (‘Mursla’ pronounced in Japanese), and the increasing ability to decode the complex language of biology (‘Bio’) Mursla Bio
The Bradfield Centre is a purpose built collaborative scale up space in the heart of the world famous Cambridge Science Park. The building has been designed to encourage the collision of ideas and to spark creativity. By basing your tech business here you can enjoy inclusive access to everything we have to offer. The Bradfield Centre’s facilities are designed to accelerate businesses to new levels. The aim is to attract smart, ambitious, like-minded entrepreneurs and companies from both Cambridge and around the world; co-locate them in scalable, state-of-the-art facilities; immerse them in a collaborative, entrepreneurial culture; and connect them to investors, partners, mentors, advisers and potential customers. One goal in mind – to help grow Cambridge-based tech businesses to a large-scale.
MathWorks is the leading developer of mathematical computing software. Engineers and scientists worldwide rely on its products to accelerate the pace of discovery, innovation, and development. MATLAB, the language of technical computing, is a programming environment for algorithm development, data analysis, visualization, and numeric computation. Simulink is a graphical environment for simulation and Model-Based Design for multidomain dynamic and embedded systems. MATLAB and Simulink are also fundamental teaching and research tools in the world’s universities and learning institutions. Founded in 1984, MathWorks employs more than 5000 people in 16 countries, with headquarters in Natick, Massachusetts, USA.
Cambridge, UK–based biotechnology startup developing a next-generation platform technology aimed at advancing innovation in the life sciences sector. Founded by a team of experienced scientists, entrepreneurs, and technology leaders, the company is focused on translating cutting-edge scientific research into scalable solutions with the potential to transform healthcare and biotechnology. Backed by leading investors including Oxford Science Enterprises, Nuanced Bio combines expertise in biology, engineering, and technology development to build novel capabilities for the future of biomedical research and therapeutic innovation. While the company currently operates in stealth mode, it is focused on growing its platform and team to support long-term scientific and commercial impact.
NextMove Software develops innovative informatics solutions to support strategic decision making in the pharmaceutical and chemical industries.
Novogene is a leading provider of genomic services and solutions with cutting edge NGS and bioinformatics expertise, and more advanced sequencing capacity in the world. Novogene utilizes scientific excellence, a commitment to customer service and unsurpassed data quality to help our clients realize their research goals. The company has become a world-leader in NGS services, with 2,600 employees and multiple locations across the globe. Novogene’s depth of experience has resulted in the ownership of 22 NGS-related patents, as well as the publishing of over 4920 customer research papers, often in well-respected publications such as Nature and Science . Company founder, Dr. Ruiqiang Li , is widely recognized as one of the world’s leading experts in genomics and bioinformatics, owning 17 patents and has authored over 100 publications that have been cited more than 42,000 times. Best known for developing the software SOAP ( Short Oligonucleotide Analysis Package) for ultra-fast sequence mapping, variation detection, and de novo genome assembly, Dr. Li has focused Novogene’s services on performing sequencing AND Advisory informatics to fully empower and enable our customers to move forward rapidly and effectively in their scientific Endeavors.
Pioneers in virtual reality applications for neuroscience, Neuro XR creates immersive environments that aid in the study and treatment of neurological conditions.
Napp is a privately owned UK company with a strong track record in bringing high quality, innovative medicines to UK health professionals and their patients. Napp provides prescription only medicines for respiratory diseases, such as asthma, inflammatory conditions, such as Crohn’s disease, ulcerative colitis, ankylosing spondylitis, rheumatoid arthritisand psoriasis, as well as pain management, blood cancers and cardiovascular conditions. Based in the heart of the Cambridge science community, and part of a worldwide network of independent associated companies across 48 countries, Napp prides itself on being an ambitious, asset led, customer-focused and sales driven organisation.
Developing a breathalyzer for disease – with a focus on non-invasive diagnostics for cancer, inflammatory disease and infectious disease, the company aims to save 100,000 lives and $1.5B in healthcare costs. Owlstone Medical’s mission is to save 100,000 lives and $1.5 billion in healthcare costs by developing Breath Biopsy® for applications in early detection and precision medicine across a wide range of diseases. Breath Biopsy detects biomarkers on breath such as volatile organic compounds (VOCs) and respiratory droplets. VOC biomarkers originate from within the body as a result of metabolic and disease processes as from external sources including diet, environmental exposures and the microbiome. They are carried in the blood and exchange into breath in the lungs. Respiratory droplets arise in the lungs and are a medium for respiratory disease transmission as well as a source of macromolecular and non-volatile biomarkers. Owlstone Medical is establishing a new diagnostic modality in breath with distinct advantages over existing approaches. The company offers an end-to-end platform for sample collection and analysis to support clinicians, academics and pharmaceutical researchers. Their Breath Biopsy Collection station, including ReCIVA® Breath Sampler enables non-invasive sampling with background reduction and pre-concentration to maximize sensitivity. Owlstone Medical provides comprehensive sample analysis services through the Breath Biopsy OMNI Assay that delivers high quality biomarker discovery, identification and validation using Thermo Fisher™ GC-Orbitrap™ technologies. You can also target specific processes for precision analysis with EVOC® Probes; using administered exogenous VOCs to precisely assay metabolic pathways of interest.
Oxford Gene Technology (OGT) provides world-class genetics research solutions to leading clinical and academic research institutions. Founded by Professor Sir Edwin Southern, and with customers in over 60 countries worldwide, OGT has a strong reputation and increasing share in the large and growing genomic medicine market. The Company’s Cytocell®, CytoSure™ and SureSeq™ range of fluorescence in situ hybridisation (FISH), microarray and next generation sequencing (NGS) products deliver high-quality genetic analysis, enabling accurate identification and confirmation of the causative variation underlying genetic disease. OGT was acquired by Sysmex Corporation (Sysmex), a Japanese in vitro diagnostic company in June 2017. The acquisition of OGT expands Sysmex’s life science business and reinforces its initiatives towards personalised medicine.
Specialist physiotherapy and wellbeing amenity located on the park, providing occupiers and visitors with convenient access to expert musculoskeletal assessment, treatment, and rehabilitation services.
Convenient on-site barbers that provides occupiers and visitors with professional barbering services in a modern and welcoming environment.
Convenient on-site amenity that supports sustainable travel and active commuting across the park. Providing secure bicycle storage, maintenance facilities, and cyclist-focused services, the hub is designed to make cycling a practical and attractive transport option for occupiers and visitors. By encouraging healthier, low-carbon journeys to and from work, The Cycle Hub contributes to the park’s sustainability objectives while enhancing the wellbeing and convenience of its community.
Global contract development and manufacturing organization (CDMO) that partners with leading pharmaceutical, medical technology, and diagnostic companies to design, develop, and manufacture innovative healthcare products. A subsidiary of Molex and backed by Koch, Phillips-Medisize specializes in drug delivery systems, medical devices, diagnostic solutions, and connected health technologies. With more than 6,500 employees and approximately 30 development and manufacturing sites across North America, Europe, and Asia, the company provides end-to-end services spanning product design, engineering, regulatory support, and large-scale manufacturing. Leveraging over 60 years of expertise, Phillips-Medisize helps healthcare innovators bring high-quality, patient-centered products to market that improve outcomes and enhance quality of life worldwide.
Sustainable bio-based material for fashion PACT’s mission is to reduce the environmental impact from raw materials used in fashion, which is the main path in making this industry less polluting and more sustainable. Leather has one of the highest impacts, including water pollution with heavy metals, significant land use and carbon footprint as it derives from the cattle industry. By turning waste-derived collagen into a biomaterial that mimics leather, we create a scalable environmentally-friendly, sustainable and bio-based substitute to leather.
Pragmatic Semiconductor is a world leader in ultra low cost flexible electronics, enabling the potential for trillions of “smart objects” that can sense and communicate with their environment. Pragmatic Semiconductor’s unique technology platform enables integrated circuits thinner than a human hair that can be easily embedded in any surface, introducing interactivity into a wide range of everyday items. At a fraction of the price of conventional silicon chips, Pragmatic Semiconductor’s products enable a vast range of new applications: from intelligent packaging of fast-moving consumer goods, to wireless traceability of documents for security and identification. Pragmatic Semiconductor is headquartered in Cambridge, England and has a production facility based at the National Centre for Printable Electronics in Sedgefield. Pragmatic Semiconductors growing customer base includes large multi-national customers across a number of sectors, including consumer goods, packaging, security printing and mainstream electronics.
UK-based technology company specialising in AI-driven content distribution and media optimisation solutions. The company develops software that enables creators and businesses to transform long-form video content into multiple publish-ready formats across platforms such as YouTube, podcasts, and short-form social media channels. By automating content repurposing, compliance, and performance tracking, Ramblox helps organisations scale their digital output more efficiently while improving audience reach and engagement. Based in Cambridge, the company operates within the artificial intelligence and digital media technology sector, focusing on tools that streamline modern content production workflows.
Premium fitness amenity located on the park, providing occupiers with convenient access to modern health and wellbeing facilities. The gym offers a comprehensive range of strength, cardio, and functional training equipment, alongside flexible membership options designed to support a wide variety of fitness goals. By promoting employee wellbeing, work-life balance, and an active lifestyle, Revolution Fitness enhances the park’s amenity offering and contributes to a healthy, productive environment for businesses and their teams.
Roundpoint has developed and managed mobile services and apps right from the start of ‘mobile’ itself. Today our focus is on scholarly publishing and learning services for professional societies and medical associations. Our expertise involves the creation of an online platform designed to simplify the process of building and managing digital learning to the highest standards.
With over 54,000 members and an international publishing and knowledge business we are the UK’s professional body for chemical scientists, supporting and representing our members and bringing together chemical scientists from all over the world. A not-for-profit organisation with a heritage that spans 175 years, we have an ambitious international vision for the future. Around the world, we invest in educating future generations of scientists. We raise and maintain standards. We partner with industry and academia, promoting collaboration and innovation. We advise governments on policy. And we promote the talent, information and ideas that lead to great advances in science. In a complex and changing world, chemistry and the chemical sciences are essential. They are vital in our everyday lives and will be vital in helping the world respond to some of its biggest challenges. We are committed to promoting, supporting and celebrating inclusion and diversity. We understand that the success of our community depends on our ability to nurture the talent of the best people regardless of who they are or their background. We’re working to shape the future of the chemical sciences – for the benefit of science and humanity.
Computing for everybody. From industries large and small, to the kitchen table tinkerer, to the classroom coder, we make computing accessible and affordable for everybody.
Roku pioneered streaming for the TV, & we aspire to power every TV in the world. We developed a streaming platform that delivers a best-in-class user experience. At the heart of the Roku platform is our proprietary operating system, the Roku OS, which we built from the ground up. Roku is recognized for streaming innovation
UK-based artificial intelligence company developing advanced AI solutions to help organisations extract insights from complex data and improve decision-making. The company focuses on applying machine learning, data analytics, and intelligent automation to solve real-world challenges across industry, enabling more efficient processes, enhanced operational performance, and smarter digital services. By combining expertise in artificial intelligence, software development, and data-driven innovation, SenseAI Innovations supports organisations in adopting emerging technologies and unlocking the value of their data.
engineering consultancy providing technical expertise and advisory services across the design, development, and delivery of complex engineering projects. The company supports clients with engineering analysis, project planning, systems integration, and technical problem-solving, helping organisations optimise performance, manage risk, and deliver projects efficiently. Drawing on multidisciplinary engineering knowledge and industry experience, Sejdijaj Engineering Consulting works with clients to develop practical, innovative solutions that address technical and operational challenges across a range of sectors.
Specialist osteopathic and wellbeing amenity located on the park, offering occupiers and visitors convenient access to expert musculoskeletal care and treatment.
Cambridge, UK–based biotechnology company focused on the discovery and development of innovative cancer therapies for patients with significant unmet medical needs. Founded in 2005, the company specializes in creating highly selective small-molecule drug candidates targeting primary brain tumours and cancers that frequently metastasize to the brain. Sentinel Oncology combines expertise in medicinal chemistry, cancer biology, and drug development to advance a pipeline of targeted oncology treatments, with several late-stage preclinical and clinical-stage programs. Through strategic collaborations with pharmaceutical and biotechnology partners, the company aims to improve survival outcomes and quality of life for cancer patients by delivering novel, precision-based therapeutics.
Medical technology company focused on developing advanced endoluminal surgical robotics for minimally invasive gastrointestinal (GI) procedures. Founded in 2025 and backed by Olympus Corporation and Revival Healthcare Capital, the company is designing a flexible robotic platform that enables physicians to perform complex GI interventions with greater precision, control, and accessibility. Swan EndoSurgical’s mission is to improve patient outcomes by providing safer, less invasive alternatives to traditional surgery, particularly for the treatment of gastrointestinal lesions and tumors.
Simba HPC is an electronics design house specialising in hardware, software, and FPGA development for digital signal processing and accelerated computing.
SCT is a leader in the design, manufacture and supply of Industrial IoT devices, sensors and AI-driven cloud applications for remote condition monitoring in rail, energy and mining.We transform critical infrastructure operations through actionable insights with smart monitoring solutions designed for predictive and preventative maintenance.Our solutions extend asset life, reduce maintenance costs and delays, and avert catastrophic failures. SCT has a multidisciplinary team for in-house electronics, mechanical and software design, development, testing and production. This means the company can develop new products rapidly in response to changing market needs, with its R&D hub acting as an incubator for fresh ideas. SCT’s focus on predictive and preventative maintenance means there is an appetite to respond to new requirements and facilitate potential future development based on a consultative approach with customers.
Technology and Professional Recruitment Services SoCode offer a highly personalised and consultative recruitment solution operating in the Technology and Professional Services Sector. Founded by genuine recruitment industry leaders, our multi-award-winning team spans over a decade of recruitment expertise. Specialising within the Cambridge market, and reaching across the east of England we have built strong relationships across our specialised sectors. We operate out of Norwich and now Cambridge with our recent expansion to the Cambridge Science Park following on from our highly successful growth. Since our launch in 2016 we have made over 600 placements in Cambridge, -making us one of the most successful independent recruitment start-ups’ in the UK. We achieved this with our successful formula of offering a highly personalised and consultative recruitment solution to Start Up, High Growth and Blue-Chip Clients. Unlike most recruitment companies we are not driven by KPI’s or Sales but by our customer satisfaction and service delivery levels. Linked in
SwiftDx’s portfolio of patented technologies enable ultra-boosted sensitivity lateral flow diagnostics for diseases which are undetectable with current lateral flow test technology.SwiftDx has successfully completed the initial technology development phase and is ready to commercialise its DNA detection and eAMP technologies. The company’s first product (the SwiftDx Mycoplasma Detection kit) has been launched and a further products are in development. SwiftDx’s goal is to better inform patients and healthcare practitioners with a new generation of lateral flow tests.
Sandoz (SIX: SDZ; OTCQX: SDZNY) is the global leader in generic and biosimilar medicines, with a growth strategy driven by its Purpose: pioneering access for patients. More than 20,000 people of 100 nationalities work together to ensure 900 million patient treatments are provided by Sandoz, generating substantial global healthcare savings and an even larger social impact. Its leading portfolio of approximately 1,300 products addresses diseases from the common cold to cancer. Headquartered in Basel, Switzerland, Sandoz traces its heritage back to 1886. Its history of breakthroughs includes Calcium Sandoz in 1929, the world’s first oral penicillin in 1951, and the world’s first biosimilar in 2006. In 2024, Sandoz recorded net sales of USD 10.4 billion. www.sandoz.com
SI Sensors is a division of Specialised Imaging Limited based in Cambridge and focused on Advanced Image Sensor Development. Specialised Imaging Limited is a dynamic company focusing on the design, manufacture, service and supply of ultra-high-speed imaging systems and components for industrial, defense and scientific applications.
Global biopharmaceutical company headquartered in Japan, focused on the research, development, and commercialization of innovative medicines across core therapeutic areas including oncology, rare diseases, neuroscience, gastroenterology, and plasma-derived therapies. Founded in 1781, Takeda is one of the world’s oldest pharmaceutical companies and has evolved into a research-driven organisation with a strong global footprint spanning North America, Europe, and Asia. The company is committed to addressing significant unmet medical needs by advancing biologic and small-molecule therapies, as well as plasma-based treatments, with a focus on patient-centric innovation and long-term healthcare impact.
Welcoming café and coffee amenity located on the park, providing occupiers and visitors with high-quality barista-crafted coffee, refreshments, and light food options throughout the day.
The Cambridge Research Laboratory (CRL) was Toshiba’s first overseas corporate R&D laboratory. Established in 1991, CRL is a world leading industrial research centre dedicated to fostering innovation through basic and applied research in physics, engineering and computer science. Its research areas include quantum information processing, speech and computer vision technology.
We’re part of China’s largest family of nearly 200 innovation spaces, present in every major city in China, and our mission is to help startups, businesses and organizations in the UK to enter the Chinese market easily and securely. We invite you to join us and to work with us: either through one of our science parks in Cambridge and Newcastle, or as a national partner interested in cross-border activity with China.
Helping people from all backgrounds to learn the practical and personal skills needed to be a great employee Tech Educators provide instructor-led Software Development Bootcamps and Unity Game Development Bootcamps and help people from all backgrounds to learn the practical and personal skills needed to be a great employee.
Tesu Health, established in January 2022, is a forward-thinking prescription digital therapeutics (DTx) start-up dedicated to providing effective treatment solutions for individuals facing chronic diseases. Our strides since inception are attributed to a proficient team of experts in software engineering, clinical medicine, pharmaceuticals, and private health insurance. Now headquartered in the esteemed Cambridge Science Park, Tesu Health is poised for global expansion. Our focus on research and development, coupled with robust sales and marketing initiatives, aims to propel us into the international arena, with the ultimate vision of becoming a leading global digital therapeutics company. Anchored by a well-defined business plan encompassing market analysis, financial projections, and a strong management team, Tesu Health is confident in its ability to deliver positive outcomes for investors, customers, and stakeholders. In essence, our innovative fusion of cutting-edge technology and clinical expertise positions Tesu Health as a transformative force in reshaping the treatment paradigm for individuals with chronic diseases.
Plant-based café and refreshment amenity located on the park, offering occupiers and visitors a range of high-quality coffee, vegan food, and freshly prepared refreshments.
VBuddies is a Cambridge-based software technology company developing AI-powered memoir creation platfVBuddies Ltd is a Cambridge-based software company with a patent pending application with UK IPO (GB2609962.2, filed 28 April 2026).
VBuddies is building an AI platform for cognitive health and care powered by memoir creation.
When someone tells their personal story through VBuddies, three things happen. Their family receives a precious memoir. Personalised memory tasks keep the person cognitively engaged at home, while their clinician receives continuous cognitive insights between appointments. Their care team can generate CQC-compliant care plans, brief every caregiver before each shift, and keep care profiles current through an observation loop.
VBuddies is actively speaking with investors, memory clinic partners, care organisations, and research organisations. We invite you to visit vbuddies.ai and get in touch.
orm, simply by speaking.
Full service European intellectual property firm
Veranova is a global leader in the development and manufacturing of specialist and complex active pharmaceutical ingredients (APIs) for pharma and biotech customers. Cambridge Veranova is an established provider of solid form services, including polymorph studies, salt selection, co-crystallization, chiral separations and process scale up that are critical to successful drug discovery and development.
Vital Signs Solutions is an early-stage, venture backed company with a founding team that has over 30 years experience in point of care diagnostics, consumer technology and healthcare. We have an extensive network of some of the best investors and advisors across the medtech, digital health and consumer technology sectors. Why are we doing what we’re doingSome of the biggest cost-centres and most fatal diseases in the world today can be prevented through individuals making personal changes to the way they lead their lives. Traditional health & care solutions are struggling under the weight of increased demand for services with restricted financial resources and are based on a paradigm which treats the disease – not preventing the disease occurring in the first place. Many of the major global health problems can only be overcome through solutions that allow people to manage their own health, so called “self management” or “patient activation”. We are developing these solutions in conjunction with health & care professionals, to ensure they align with the major public health priorities and standards.
Vitrolife is a global company contributing products within the IVF field. Our mission is to support customers to achieve successful treatment outcomes by providing valued solutions and services for assisted reproduction. Founded in 1994 Vitrolife was one of the first companies providing IVF laboratories with high quality ready-to-use culture media. Today our portfolio holds products all the way from oocyte retrieval to transfer of the embryo and cryopreservation. Vitrolife has approximately 400 employees and the headquarter is located in Sweden with additional locations and production facilities in more than ten countries world-wide. The Vitrolife share is listed on NASDAQ OMX Stockholm, Nordic Large Cap. Together with our customers, our mutual skills and experiences, we successfully treat infertility. Together. All the way.
VaxEquity is a UK biotechnology company developing next generation self-amplifying RNA and mRNA therapeutics and vaccines. Our proprietary RNA platform is designed to modulate the innate immune response to enable higher and longer protein expression allowing lower doses and expanding the potential of RNA for therapeutics as well as vaccines. VaxEquity was founded in 2020 by Imperial College London’s Professor Robin Shattock, and specialist life sciences investor Morningside, and is led by a world class team who are RNA pioneers. The Company is based in Cambridge, UK, and is collaborating with AstraZeneca to progress its platform across multiple disease areas.
Vectura is an emerging pharmaceutical company developing a range of inhaled drugs for the treatment of lung diseases and conditions where delivery via the lungs can provide significant benefits. Vectura also actively licenses out its inhalation device and formulation technologies for product applications of other pharmaceutical companies and can provide pharmaceutical development support to its licensing partners and other long-term collaborators.
Integrated photonics uses the same scalable process used to make semiconductor electronics chips to make circuits for light. It’s being used as the platform for energy-efficient communications for AI and data centres, wearable healthcare sensors, rapid diagnostic tools, optical tensor processors, on-chip lidar, quantum technologies and a host of other transformative applications. Wave Photonics is building design technology to enable and accelerate the development, mass production and adoption of these technologies. Wave Photonics
Worldpay is a leading payments company with global reach. We provide an extensive range of technology-led payment products and services to over 400,000 customers, enabling their businesses to grow and prosper. We manage the increasing complexity of the payments landscape for our customers, allowing them to accept the widest range of payment types around the world. Using our network and technology, we are able to process payments from geographies covering 99% of global GDP, across 146 countries and 126 currencies. We help our customers to accept more than 300 different payment types.
Quantum technology company developing next-generation timing and synchronization solutions for critical infrastructure, telecommunications, transportation, finance, and defence applications. The company has pioneered a proprietary Quantum Time Transfer (QTT) technology that uses quantum communications and optical systems to deliver highly accurate, secure, and resilient timing services, providing an alternative to traditional GPS and GNSS-based systems. By addressing vulnerabilities such as signal jamming and spoofing, Xairos aims to enable a new generation of Position, Navigation, and Timing (PNT) capabilities that support the reliability and security of increasingly connected global networks. With operations in both the United States and the United Kingdom, the company is advancing the commercialization of quantum-enabled timing technologies for government and commercial customers worldwide.
Natural alternatives to single-use plastic Xampla has created the world’s first plant protein material for commercial use. Our next generation material performs like synthetic polymers, but decomposes naturally and fully, without harming the environment. Our mission is to replace the everyday single-use plastics you see all around, like bags, sachets and flexible packaging films. And the less obvious, such as microplastics within liquids and lotions.
XGenomes’ mission is to revolutionize precision research and medicine through streamlined sample-to-answer solutions that exceed existing technologies across several metrics. XGenomes’ platform leverages super-resolution single-molecule imaging, deep learning and novel sequencing chemistry.
UK-based digital health and wellbeing platform focused on improving access to personalised mental health support through technology. The company provides a digital service that helps individuals connect with therapeutic resources and structured wellbeing tools designed to support emotional resilience, stress management, and overall mental wellness. By combining behavioural science, digital engagement tools, and accessible care pathways, Ziphii aims to make mental health support more immediate, scalable, and user-friendly for individuals and organisations. Its platform is designed to complement traditional healthcare services by enabling earlier intervention and ongoing wellbeing support in a flexible, digital format.
